LipiControl
94/100
This product looks safe
- Niacin: 334mg is 9.5× the Tolerable Upper Intake Level (35mg)
- 50% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 334mg is 9.5× the Tolerable Upper Intake Level (35mg)
Label Data
2 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
334 mg
(1670% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 9.5× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
700 mg
📊 Market median: 1000.0mg (223 products)
📚 11 studies (Tier A: 0, B: 5)
Gugulipid (commiphora mukul) gum extract
250 mg
Beta-Sitosterol Complex
110 mg
Gamma Oryzanol
100 mg
85 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
Other Ingredients
Hydroxypropylmethylcellulose
L-Leucine
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Directions: Take 2 capsules three times per day with meals.
⚠️ Warnings & Precautions
Keep out of reach of children.
Additional Information
Code Number: 1960
LABORATORY TESTED QUALITY & PURITY
Keep container tightly closed in a cool, dry and dark place.
TESTED FOR QUALITY & PURITY
This product is manufactured in accordance with current Good Manufacturing Practices (GMP).
300-VRP1960-M
Since 1979
VRP
Product Details
UPC / SKU
8 92727 00007 0
DSLD Entry Date
2014-06-25
Product Type
Other Combinations
Form
Capsule
DSLD ID
34046
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100